Bovie Medical Co. (NYSE:BVX) has received an average broker rating score of 1.00 (Strong Buy) from the one analysts that cover the company, Zacks Investment Research reports. One research analyst has rated the stock with a strong buy recommendation.
Brokers have set a 1-year consensus price objective of $4.50 for the company and are forecasting that the company will post ($0.03) earnings per share for the current quarter, according to Zacks. Zacks has also assigned Bovie Medical an industry rank of 180 out of 265 based on the ratings given to its competitors.
A number of equities analysts have recently issued reports on the company. Zacks Investment Research downgraded Bovie Medical from a “buy” rating to a “hold” rating in a research report on Tuesday. JMP Securities reissued an “outperform” rating and set a $5.00 price target on shares of Bovie Medical in a research report on Wednesday, August 3rd.
In other news, insider John J. Mccarthy III purchased 90,750 shares of the company’s stock in a transaction dated Wednesday, August 17th. The shares were acquired at an average price of $3.30 per share, with a total value of $299,475.00. Following the transaction, the insider now owns 115,750 shares of the company’s stock, valued at $381,975. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website.
A hedge fund recently raised its stake in Bovie Medical stock. Renaissance Technologies LLC increased its position in shares of Bovie Medical Co. (NYSE:BVX) by 37.6% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 127,000 shares of the medical device company’s stock after buying an additional 34,700 shares during the period. Renaissance Technologies LLC owned 0.47% of Bovie Medical worth $212,000 at the end of the most recent reporting period.
Shares of Bovie Medical (NYSE:BVX) traded up 1.55% during trading on Thursday, reaching $5.25. The company’s stock had a trading volume of 80,510 shares. Bovie Medical has a 12-month low of $1.56 and a 12-month high of $5.69. The stock’s market capitalization is $142.02 million. The firm’s 50-day moving average is $4.39 and its 200-day moving average is $2.51.
About Bovie Medical
Bovie Medical Corporation (Bovie) is an energy-based medical device company. The Company is engaged in the design, development and manufacturing of electrosurgical equipment by producing equipment for medical device manufacturers through original equipment manufacturing (OEM) agreements, as well as start-up companies.